XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Incentive Plans (Tables)
9 Months Ended
Sep. 30, 2021
2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the nine months ended September 30, 2021, are presented in the table below:

Schedule of Stock Option Activity 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding, December 31, 2020   14,251,000   $0.083    8.3   $- 
Granted   3,035,800   $0.085    10.0   $- 
Exercised   -                
Forfeited   (287,000)  $0.122    6.6   $- 
Expired   -                
Outstanding, September 30, 2021   16,999,800   $0.083    7.9   $- 
Exercisable, September 30, 2021   15,249,800   $0.085    7.7   $- 
Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the nine months ended September 30, 2021, are presented in the table below:

 Summary of Non-vested Non-qualified Stock Option Activity

   Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                
Nonvested, December 31, 2020   -   $-   $-   $- 
Granted   3,035,800   $0.082   $-   $- 
Vested   (1,285,800)  $0.112   $66,412   $- 
Forfeited   -             $- 
Expired   -             $- 
Nonvested, September 30, 2021   1,750,000   $0.061   $-   $104,800 
2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the nine months ended September 30, 2021, are presented in the table below:

 Schedule of Stock Option Activity

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value ($000) 
                 
Outstanding, December 31, 2020   7,400,000   $0.067    7.5   $- 
Granted   230,770   $0.065    10.0   $- 
Exercised   -                
Forfeited/Cancelled   -                
Expired   -                
Outstanding, September 30, 2021   7,630,770   $0.067    6.8   $- 
Exerciseable, September 30, 2021   7,630,770   $0.067    6.8   $- 
Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the nine months ended September 30, 2021, are presented in the table below:

Summary of Non-vested Non-qualified Stock Option Activity 

   Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                
Nonvested, December 31, 2020   1,000,000   $0.029   $31,000   $- 
Granted   230,770    0.065   $(1,154)  $- 
Vested   (1,230,770)  $0.036   $(29,846)  $- 
Forfeited   -                
Expired   -                
Nonvested, September 30, 2021   -        $-   $-